| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |